NCT06678113View on ClinicalTrials.gov

Study to Assess the Safety and Efficacy of Intravenous BSG005 in Patients With Invasive Fungal Infection

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

April 1, 2026

Conditions

Invasive Fungal Infection

Interventions

DRUG

BSG005

Single arm dose escalation in patients with invasive fungal infection

Trial Locations (1)

121003

RECRUITING

JSS Medical Research Asia Pacific Private Limited, Dehli

Sponsors

Lead Sponsor

Collaborators (1)

Alkem Laboratories Ltd

All Listed Sponsors

collaborator

Alkem Laboratories Ltd

INDUSTRY

collaborator

JSS Medical Research Asia pacific Private Limited

UNKNOWN

lead

Biosergen AS

INDUSTRY